Literature DB >> 19734219

Innate immunity against bacterial infection following hyperoxia exposure is impaired in NRF2-deficient mice.

Narsa M Reddy1, Vegiraju Suryanarayana, Dhananjaya V Kalvakolanu, Masayuki Yamamoto, Thomas W Kensler, Paul M Hassoun, Steven R Kleeberger, Sekhar P Reddy.   

Abstract

Oxygen supplementation is used as therapy to support critically ill patients with severe respiratory impairment. Although hyperoxia has been shown to enhance the lung susceptibility to subsequent bacterial infection, the mechanisms underlying enhanced susceptibility remain enigmatic. We have reported that disruption of NF-E2-related factor 2 (Nrf2), a master transcription regulator of various stress response pathways, enhances susceptibility to hyperoxia-induced acute lung injury in mice, and have also demonstrated an association between a polymorphism in the NRF2 promoter and increased susceptibility to acute lung injury. In this study, we show that Nrf2-deficient (Nrf2(-/-)) but not wild-type (Nrf2(+/+)) mice exposed to sublethal hyperoxia succumbed to death during recovery after Pseudomonas aeruginosa infection. Nrf2-deficiency caused persistent bacterial pulmonary burden and enhanced levels of inflammatory cell infiltration as well as edema. Alveolar macrophages isolated from Nrf2(-/-) mice exposed to hyperoxia displayed persistent oxidative stress and inflammatory cytokine expression concomitant with diminished levels of antioxidant enzymes, such as Gclc, required for glutathione biosynthesis. In vitro exposure of Nrf2(-/-) macrophages to hyperoxia strongly diminished their antibacterial activity and enhanced inflammatory cytokine expression compared with Nrf2(+/+) cells. However, glutathione supplementation during hyperoxic insult restored the ability of Nrf2(-/-) cells to mount antibacterial response and suppressed cytokine expression. Thus, loss of Nrf2 impairs lung innate immunity and promotes susceptibility to bacterial infection after hyperoxia exposure, ultimately leading to death of the host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19734219      PMCID: PMC2820249          DOI: 10.4049/jimmunol.0901754

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

Review 1.  Receptors for unopsonized particles: the role of alveolar macrophage scavenger receptors.

Authors:  A Palecanda; L Kobzik
Journal:  Curr Mol Med       Date:  2001-11       Impact factor: 2.222

2.  Role of NRF2 in protection against hyperoxic lung injury in mice.

Authors:  Hye-Youn Cho; Anne E Jedlicka; Sekhar P M Reddy; Thomas W Kensler; Masayuki Yamamoto; Liu-Yi Zhang; Steven R Kleeberger
Journal:  Am J Respir Cell Mol Biol       Date:  2002-02       Impact factor: 6.914

3.  Multicenter prospective study of ventilator-associated pneumonia during acute respiratory distress syndrome. Incidence, prognosis, and risk factors. ARDS Study Group.

Authors:  P Markowicz; M Wolff; K Djedaïni; Y Cohen; J Chastre; C Delclaux; J Merrer; B Herman; B Veber; A Fontaine; D Dreyfuss
Journal:  Am J Respir Crit Care Med       Date:  2000-06       Impact factor: 21.405

Review 4.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

5.  Differential particulate air pollution induced oxidant stress in human granulocytes, monocytes and alveolar macrophages.

Authors:  S Becker; J M Soukup; J E Gallagher
Journal:  Toxicol In Vitro       Date:  2002-06       Impact factor: 3.500

6.  Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1.

Authors:  Mary E Davey; Nicky C Caiazza; George A O'Toole
Journal:  J Bacteriol       Date:  2003-02       Impact factor: 3.490

7.  Reversible S-glutathionylation of Cys 374 regulates actin filament formation by inducing structural changes in the actin molecule.

Authors:  I Dalle-Donne; D Giustarini; R Rossi; R Colombo; A Milzani
Journal:  Free Radic Biol Med       Date:  2003-01-01       Impact factor: 7.376

Review 8.  Regulatory mechanisms controlling gene expression mediated by the antioxidant response element.

Authors:  Truyen Nguyen; Philip J Sherratt; Cecil B Pickett
Journal:  Annu Rev Pharmacol Toxicol       Date:  2002-01-10       Impact factor: 13.820

Review 9.  Antioxidant responses to oxidant-mediated lung diseases.

Authors:  Suzy A A Comhair; Serpil C Erzurum
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-08       Impact factor: 5.464

10.  Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia.

Authors:  Yoshiaki Kikuchi; Kazuhiro Tateda; Etsu T Fuse; Tetsuya Matsumoto; Naomasa Gotoh; Jun Fukushima; Hajime Takizawa; Takahide Nagase; Theodore J Standiford; Keizo Yamaguchi
Journal:  Pulm Pharmacol Ther       Date:  2009-01-08       Impact factor: 3.410

View more
  32 in total

1.  Thiol redox disturbances in children with severe asthma are associated with posttranslational modification of the transcription factor nuclear factor (erythroid-derived 2)-like 2.

Authors:  Anne M Fitzpatrick; Susan T Stephenson; Graham R Hadley; Leandrea Burwell; Madhuri Penugonda; Dawn M Simon; Jason Hansen; Dean P Jones; Lou Ann S Brown
Journal:  J Allergy Clin Immunol       Date:  2011-04-22       Impact factor: 10.793

2.  Glutathione oxidation is associated with airway macrophage functional impairment in children with severe asthma.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Leandrea Burwell; Meredith S Brown; Lou Ann S Brown
Journal:  Pediatr Res       Date:  2011-02       Impact factor: 3.756

3.  Nrf2 deficiency in myeloid cells is not sufficient to protect mice from high-fat diet-induced adipose tissue inflammation and insulin resistance.

Authors:  Akshaya K Meher; Poonam R Sharma; Vitor A Lira; Masayuki Yamamoto; Thomas W Kensler; Zhen Yan; Norbert Leitinger
Journal:  Free Radic Biol Med       Date:  2012-02-24       Impact factor: 7.376

4.  Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.

Authors:  Kai Takaya; Takafumi Suzuki; Hozumi Motohashi; Ko Onodera; Susumu Satomi; Thomas W Kensler; Masayuki Yamamoto
Journal:  Free Radic Biol Med       Date:  2012-06-23       Impact factor: 7.376

5.  Oxidative stress fuels Trypanosoma cruzi infection in mice.

Authors:  Claudia N Paiva; Daniel F Feijó; Fabianno F Dutra; Vitor C Carneiro; Guilherme B Freitas; Letícia S Alves; Jacilene Mesquita; Guilherme B Fortes; Rodrigo T Figueiredo; Heitor S P Souza; Marcelo R Fantappié; Joseli Lannes-Vieira; Marcelo T Bozza
Journal:  J Clin Invest       Date:  2012-06-25       Impact factor: 14.808

Review 6.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

7.  Inhibition of high-mobility group box 1 protein (HMGB1) enhances bacterial clearance and protects against Pseudomonas Aeruginosa pneumonia in cystic fibrosis.

Authors:  Maria Entezari; Daniel J Weiss; Ravikumar Sitapara; Laurie Whittaker; Matthew J Wargo; JianHua Li; Haichao Wang; Huan Yang; Lokesh Sharma; Binh D Phan; Mohammad Javdan; Sangeeta S Chavan; Edmund J Miller; Kevin J Tracey; Lin L Mantell
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

8.  Association of Nrf2 polymorphism haplotypes with acute lung injury phenotypes in inbred strains of mice.

Authors:  Hye-Youn Cho; Anne E Jedlicka; Wesley Gladwell; Jacqui Marzec; Zackary R McCaw; Rachelle J Bienstock; Steven R Kleeberger
Journal:  Antioxid Redox Signal       Date:  2014-11-12       Impact factor: 8.401

9.  Nuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activation.

Authors:  Changcheng Zhao; Devyn D Gillette; Xinghui Li; Zhibin Zhang; Haitao Wen
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

10.  Nrf2 Modulates Host Defense during Streptococcus pneumoniae Pneumonia in Mice.

Authors:  John C Gomez; Hong Dang; Jessica R Martin; Claire M Doerschuk
Journal:  J Immunol       Date:  2016-08-26       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.